# MilliporeSigma signs viral vector supply agreement with bluebird bio

MilliporeSigma signed a commercial supply agreement to manufacture lentiviral vectors for bluebird bio's gene therapies for rare genetic diseases. The multi-year agreement covers manufacturing at MilliporeSigma's Carlsbad, California facility.

- Type: Contract
- Announced: 2017-12-20
- Where: Carlsbad, California, United States
- Status: completed
- Products: lentiviral vectors for gene therapy
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [MilliporeSigma](https://endata.com/companies/7341.md)
- [bluebird bio](https://endata.com/companies/20764.md) (customer)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/milliporesigma-signs-commercial-supply-agreement-with-bluebird-bio-for-viral-vector-manufacturing-300572800.html), 2017-12-20: "We look forward to collaborating with bluebird bio to bring to market breakthrough therapies to fight diseases for which there are limited or no options."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.